Drawing for MN PHARMACEUTICALS

USPTO serial 79038809

MN PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 3409462Status 709
Filing date
Status date
Registration date
Apr 8, 2008
Examiner
BROMAGHIM, PETER
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MN PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical Preparations For The Treatment Of Infectious Diseases, Namely, Skin Ands Soft Tissue Infections, Gastrointestinal Infections, Intraabdominal Infections, Gynecological Infections, Respiratory Tract Infections, Endocarditis, Septicemia, Bone And Joint Infections, Neoplastic Diseases, Hematologic Disorders, Cardiovascular Diseases, Endocrine Disorders, Hypercalcemia Of Malignancy, Gastrointestinal Diseases, Allergic States, Rheumatic Disorders, Nervous System Disorders, Muscle Diseases, Neuromuscular Blockage In General Anesthesia And As Imaging Agents, Veterinary Preparations For The Treatment Of Infectious Diseases; Sanitary Preparations For Medical Purposes; Dietetic Foods Adapted For Medical Use, Food For Babies; Medical Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants For Hygienic Purposes; Preparations For Destroying Vermin; Fungicides, And HerbicidesSECTION 71 - CANCELLED—
044Medical Services; Pharmaceutical Dispensing And Consultation Services; Veterinary Services; Hygienic And Beauty Care For Human Beings And Animals; Agriculture, Horticulture And Forestry Services All For The Treatment Of Infectious Diseases, Namely, Skin And Soft Tissue Infections, Gastrointestinal Infections, Intraabdominal Infections, Gynecological Infections, Respiratory Tract Infections, Endocarditis, Septicemia, Bone And Joint Infections, Neoplastic Diseases, Hematologic Disorders, Cardiovascular Diseases, Endocrine Disorders, Hypercalcemia Of Malignancy, Gastrointestinal Diseases, Allergic States, Rheumatic Disorders, Nervous System Disorders, Muscle Diseases, Neuromuscular Blockage In General Anesthesia And As Imaging AgentsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 1, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 20, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 11, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 24, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 30, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 30, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 9, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 9, 2018C71TCANCELLED SECTION 71—
Apr 8, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Aug 25, 2016RNWLINTERNATIONAL REGISTRATION RENEWED—
May 13, 2013NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 13, 201371AGREGISTERED-SEC.71 ACCEPTED—
May 13, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 24, 2013ES71TEAS SECTION 71 RECEIVED—
Apr 24, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 24, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 22, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 30, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 30, 2008FIMPFINAL DISPOSITION PROCESSED—
Jul 8, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 8, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 22, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2008NPUBNOTICE OF PUBLICATION—
Dec 18, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 7, 2007ALIEASSIGNED TO LIE—
Nov 1, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 30, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 30, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2007RFNTREFUSAL PROCESSED BY IB—
Jul 13, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 13, 2007RFRRREFUSAL PROCESSED BY MPU—
Jul 13, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 12, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2007DOCKASSIGNED TO EXAMINER—
Jun 29, 2007NWAPNEW APPLICATION ENTERED—
Jun 28, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance